This is the second time my heart is irregular and have tachycardia. I've completed 4 treatments r-chop. Anyone else...

⚠️ IMPORTANT - CONTACT YOUR CARE TEAM TODAY

Please reach out to your oncology team or cardiologist right away about this. Irregular heartbeat and tachycardia (fast heart rate) during chemotherapy need prompt medical evaluation—this is not something to wait on. If you're experiencing chest pain, severe shortness of breath, or fainting, go to the emergency department immediately.

---

Why This Matters During R-CHOP

You're experiencing a known side effect of one of your chemotherapy drugs. According to cardio-oncology research, doxorubicin (the "H" in R-CHOP, also called Adriamycin) is an anthracycline chemotherapy drug that can affect heart function. This is well-documented in medical literature, and your care team should be monitoring for exactly this.

Here's what's happening medically:

The Drug Effect: Doxorubicin can damage heart muscle cells, which may cause:

• Irregular heartbeats (arrhythmias)
• Increased heart rate (tachycardia)
• Weakened heart pumping ability (cardiomyopathy)

This is not a sign of weakness or something you did wrong—it's a recognized side effect of the medication itself.

---

What Your Care Team Should Be Doing

According to NCCN Guidelines and cardio-oncology standards, patients receiving R-CHOP should have:

1. Baseline heart function testing (usually an echocardiogram or MUGA scan before treatment starts)
2. Regular monitoring during treatment (typically echocardiograms between cycles)
3. Heart function checks after treatment completes

If your team hasn't done this monitoring, that's something to ask about directly.

---

Questions to Ask Your Oncology Team RIGHT NOW

1. "Can we check my heart function today or this week?" (Ask for an echocardiogram or MUGA scan)
2. "Is this a known side effect of doxorubicin, and what does it mean for my treatment plan?"
3. "Should I see a cardiologist who specializes in cancer patients (cardio-oncologist)?"
4. "Are there medications I can take to protect my heart during the remaining treatments?" (Beta-blockers or ACE inhibitors are sometimes used)
5. "What symptoms should I watch for that would require emergency care?"
6. "How will you monitor my heart for the rest of my treatment and after?"

---

Yes, Others Experience This

You're not alone. According to cardio-oncology research, doxorubicin-related heart problems are common enough that they're a standard monitoring concern. Some patients experience mild symptoms like yours; others have more significant changes. The key difference is catching it early and managing it.

The good news: Many patients complete their R-CHOP successfully with proper cardiac monitoring and sometimes heart-protective medications added to their treatment plan.

---

What to Do This Week

✅ Call your oncology team today - describe the irregular heartbeat and tachycardia
✅ Ask for urgent heart function testing (echocardiogram or MUGA scan)
✅ Ask if you need cardio-oncology referral (a cardiologist who specializes in cancer patients)
✅ Get clarity on whether your remaining R-CHOP treatments need adjustment
✅ Ask about heart-protective medications during your remaining cycles

---

Medical Sources

This information is based on:

• Cardio-Oncology Guidelines (NCCN and American Society of Clinical Oncology) on anthracycline monitoring
• R-CHOP treatment protocols which include doxorubicin as a known cardiotoxic agent
• Standard cancer care practice requiring baseline and ongoing cardiac monitoring during treatment

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your symptoms deserve prompt evaluation—please reach out to your oncology team today. This is exactly what they're trained to manage.